Trans-Species Comparison of PPAR and RXR Expression by Rat and Human Urothelial Tissues

Toxicologic Pathology

Volumn 36, Issue 3, 2008, Pages 485-495

  Chopra, Bikramjit ^a   Hinley, Jennifer ^a   Oleksiewicz, Martin B ^b   Southgate, Jennifer ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

Author keywords

bladder; Ki67; lower urinary tract; PPAR; RXR; urothelium

Indexed keywords

BIOLOGICAL MARKER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR; KI 67 ANTIGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA;

ADULT; AGED; ANIMAL; ARTICLE; BLADDER; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOLOGY; HUMAN; MALE; METABOLISM; MIDDLE AGED; RAT; SPECIES DIFFERENCE; URETER; UROTHELIUM; WISTAR RAT; ANIMAL CELL; ANIMAL TISSUE; CELL CYCLE REGULATION; CONTROLLED STUDY; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IN VITRO STUDY; MORPHOLOGY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOOTH MUSCLE; SPECIES COMPARISON; URETHRA;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RATS, WISTAR; RETINOID X RECEPTORS; SPECIES SPECIFICITY; URETER; URINARY BLADDER; UROTHELIUM;

RATTUS;

EID: 48549093258     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/0192623308315672     Document Type: Article

References (41)

1. Berger J Moller DE The mechanisms of action of PPARs Annu Rev Med 2002 53 409 35
2. Brand CL Sturis J Gotfredsen CF Fleckner J Fledelius C Hansen BF Andersen B Ye JM Sauerberg P Wassermann K Dual PPARalpha/gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats Am J Physiol Endocrinol Metab 2003 284 E841 54
3. Chang FA Jaber LA Berlie HD O’Connell MB Evolution of peroxisome proliferator-activated receptor agonists Ann Pharmacother 2007 41 973 83
4. Cohen SM Effects of PPARgamma and combined agonists on the urinary tract of rats and other species Toxicol Sci 2005 87 322 27
5. Desvergne B Wahli W Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr Rev 1999 20 649 88
6. Dominick MA White MR Sanderson TP Van Vleet T Cohen SM Arnold LE Cano M Tannehill-Gregg S Moehlenkamp JD Waites CR Schilling BE Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: evidence for urolithiasis as the inciting event in the mode of action Toxicol Pathol 2006 34 903 20
7. Dreyer C Krey G Keller H Givel F Helftenbein G Wahli W Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors Cell 1992 68 879 87
8. Egerod FL Nielsen HS Iversen L Thorup I Storgaard T Oleksiewicz MB Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo Biomarkers 2005 10 295 309
9. El-Hage J Preclinical and clinical safety assessments for PPAR agonists 2004 www.fda.gov/cder/present/DIA2004/Elhage.ppt
10. Feige JN Gelman L Michalik L Desvergne B Wahli W From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions Prog Lipid Res 2006 45 120 59
11. Guan Y Zhang Y Davis L Breyer MD Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans Am J Physiol Renal Physiol 1997 273 F1013 22
12. Hicks RM The mammalian urinary bladder: an accommodating organ Biol Rev Philos Soc 1975 50 215 46
13. Jain S Pulikuri S Zhu Y Qi C Kanwar YS Yeldandi AV Rao MS Reddy JK Differential expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse Am J Pathol 1998 153 349 54
14. Juge-Aubry C Pernin A Favez T Burger AG Wahli W Meier CA Desvergne B DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5’-flanking region J Biol Chem 1997 272 25252 59
15. Kaneko H Watanabe H Hosokawa Y Urata Y Hattori T Pellicciari C Fukuda M The presence of G1 and G2 populations in normal epithelium of rat urinary bladder Basic Appl Histochem 1984 28 41 57
16. Kersten S Desvergne B Wahli W Roles of PPARs in health and disease Nature 2000 405 421 4
17. Kim DJ Murray IA Burns AM Gonzalez FJ Perdew GH Peters JM Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity J Biol Chem 2005 280 9519 27
18. Larsen PJ Jensen PB Sørensen RV Larsen LK Vrang N Wulff EM Wassermann K Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis Diabetes 2003 52 2249 59
19. Leiter LA Can thiazolidinediones delay disease progression in type 2 diabetes? Curr Med Res Opin 2006 22 1193 201
20. Lohray BB Lohray VB Bajji AC Kalchar S Poondra RR Padakanti S Chakrabarti R Vikramadithyan RK Misra P Juluri S Mamidi NV Rajagopalan R (-)3-[4-[2-(Phenoxazin-10-yl) ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity J Med Chem 2001 44 2675 8
21. Mo L Cheng J Lee EY Sun T-T Wu XR Gene deletion in urothelium by specific expression of Cre recombinase Am J Physiol Renal Physiol 2005 289 F562 8
22. Morimura K Cheung C Ward JM Reddy JK Gonzalez FJ Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis Carcinogenesis 2006 27 1074 80
23. Nguyen MM Urothelial progenitor cells: regional differences in the rat bladder Cell Prolif 2007 40 157 65
24. Oleksiewicz MB Thorup I Nielsen HS Andersen HV Hegelund AC Iversen L Guldberg TS Brinck PR Sjogren I Thinggaard UK Jørgensen L Jensen MB Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo Toxicol Pathol 2005 33 552 60
25. Peters JM Cheung C Gonzalez FJ Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand? J Mol Med 2005 83 774 85
26. Pickavance LC Brand CL Wassermann K Wilding JP The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats Br J Pharmacol 2005 144 308 16
27. Saad MF Greco S Osei K Lewin AJ Edwards C Nunez M Reinhardt RR Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm Diabetes 2004 27 1324 9
28. Shah YM Morimura K Yang Q Tanabe T Takagi M Gonzalez FJ PPARalpha regulates miRNA-mediated signaling cascade responsible for hepatocellular proliferation Mol Cell Biol 2007 10.1128/MCB.00317-07
29. Southgate J Hutton KA Thomas DF Trejdosiewicz LK Normal human urothelial cells in vitro: proliferation and induction of stratification Lab Invest 1994 71 583 94
30. Southgate J Masters JR Trejdosiewicz LK Freshney RI Freshney MG Culture of human urothelium Culture of Epithelial Cells 2002 New York John Wiley 381 400
31. Staels B Fruchart JC Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 2005 54 2460 70
32. Stahlschmidt J Varley CL Toogood G Selby PJ Southgate J Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease Kidnet Int 2005 68 1032 40
33. Tannehill-Gregg SH Sanderson TP Minnema D Voelker R Ulland B Cohen SM Arnold LL Schilling BE Waites CR Dominick MA Rodent carcinogenicity profile of the antidiabetic dual PPAR {alpha} and {gamma} agonist muraglitazar Toxicol Sci 2007 98 258 70
34. Varley CL Garthwaite MA Cross W Hinley J Trejdosiewicz LK Southgate J PPARgamma-regulated tight junction development during human urothelial cytodifferentiation J Cell Physiol 2006 208 407 17
35. Varley C Hill G Pellegrin S Shaw NJ Selby PJ Trejdosiewicz LK Southgate J Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro Exp Cell Res 2005 306 216 29
36. Varley CL Stahlschmidt J Lee WC Holder J Diggle C Selby PJ Trejdosiewicz LK Southgate J Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme J Cell Sci 2004 15 2029 36
37. Varley CL Stahlschmidt J Smith B Stower M Southgate J Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells Am J Pathol 2004 164 1789 98
38. Varnat F Heggeler BB Grisel P Boucard N Corthésy-Theulaz I Wahli W Desvergne B PPARbeta/delta regulates paneth cell differentiation via controlling the hedgehog signaling pathway Gastroenterology 2006 131 538 53
39. Ye JM Iglesias MA Watson DG Ellis B Wood L Jensen PB Sørensen RV Larsen PJ Cooney GJ Wassermann K Kraegen EW PPARalpha/gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly Am J Physiol Endocrinol Metab 2003 284 E531 40
40. Zahradka P Wright B Fuerst M Yurkova N Molnar K Taylor CG Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration J Pharmacol Exp Ther 2006 317 651 9
41. Zahradka P Yurkova N Litchie B Moon MC Del Rizzo DF Taylor CG Activation of peroxisome proliferator-activated receptors alpha and gamma1 inhibits human smooth muscle cell proliferation Mol Cell Biochem 2003 246 105 10